Fierce Pharma reported according to data from Standard Media Index (SMI), pharma ad spend on linear TV fell by 4% YoY in 2022 while digital’s share of the media mix rose from 49.6% to 52.6%, marking a possible tipping point in the transition to digital pharma advertising.
“There has been a little bit of a replacement of ad spending dollars on TV with digital. TV is still massive, in our pool it represents $5 billion, which is a huge amount of spend by pharmaceutical advertising, but we've started to see in the last year that the shift is a little bit more pronounced,” Darrick Li, vice president of sales in North America at SMI, said. “It's pretty phenomenal that we're seeing that shift happen so quickly.”
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.